BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34648006)

  • 1. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
    Ghandour B; Dbaibo G; Darwiche N
    Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer treatment strategies targeting sphingolipid metabolism.
    Oskouian B; Saba JD
    Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.
    Shaw J; Costa-Pinheiro P; Patterson L; Drews K; Spiegel S; Kester M
    Adv Cancer Res; 2018; 140():327-366. PubMed ID: 30060815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
    Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
    Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide-based therapeutics for the treatment of cancer.
    Barth BM; Cabot MC; Kester M
    Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of bioactive sphingolipids in cancer biology and therapeutics.
    Saddoughi SA; Song P; Ogretmen B
    Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid metabolism enzymes as targets for anticancer therapy.
    Kok JW; Sietsma H
    Curr Drug Targets; 2004 May; 5(4):375-82. PubMed ID: 15134220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles and therapeutic targeting of ceramide metabolism in cancer.
    Wajapeyee N; Beamon TC; Gupta R
    Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic, non-natural sphingolipid analogs inhibit the biosynthesis of cellular sphingolipids, elevate ceramide and induce apoptotic cell death.
    Dagan A; Wang C; Fibach E; Gatt S
    Biochim Biophys Acta; 2003 Sep; 1633(3):161-9. PubMed ID: 14499735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
    Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide Signaling and p53 Pathways.
    Jeffries KA; Krupenko NI
    Adv Cancer Res; 2018; 140():191-215. PubMed ID: 30060809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
    Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
    Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
    Barui S; Saha S; Yakati V; Chaudhuri A
    Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceramide: Therapeutic Potential in Combination Therapy for Cancer Treatment.
    Li F; Zhang N
    Curr Drug Metab; 2015; 17(1):37-51. PubMed ID: 26526831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy paradox and ceramide.
    Jiang W; Ogretmen B
    Biochim Biophys Acta; 2014 May; 1841(5):783-92. PubMed ID: 24055889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.